Target: Lopital
Seller: Lopital Shareholders
Advisory sell side: BDO | M&A Advisory and Legal Advisory Corporate M&A
Buyer: Holland Capital
Advisory buy side: Orange Clover | Legal Advisory Corporate M&A
Sincerius | Financial Due Diligence
JSA Tax | Tax Advisory
Date announced: 2023-08-21

In a strategic move to further bolster its presence in the healthcare sector, Holland Capital, a leading private equity firm specialising in healthcare investments, has announced the successful acquisition of Lopital, a prominent player in the medical equipment and healthcare solutions industry.

This acquisition marks a significant milestone for both organisations, as they join forces to drive innovation and elevate the quality of healthcare services and products offered to patients and healthcare providers worldwide.

Lopital, known for its cutting-edge medical equipment, has established a reputation for producing high-quality, durable, and user-friendly solutions that enhance patient care across various healthcare settings. With a diverse product portfolio ranging from patient handling and hygiene solutions to rehabilitation and mobility aids, Lopital's offerings align seamlessly with Holland Capital's mission to invest in companies at the forefront of healthcare technology.

The acquisition not only positions Holland Capital as a major player in the healthcare solutions market but also underscores the firm's dedication to investing in companies that drive positive change in the healthcare industry.

As the healthcare landscape continues to evolve, the combined expertise and resources of Holland Capital and Lopital are poised to play a pivotal role in shaping the future of patient care, setting new standards for quality, accessibility, and innovation in healthcare solutions.

Holland Capital